Atlas Trials

The Effects of Inhaled Budesonide-formoterol-glycopyrronium in Moderate-to-severe COPD

Clinical trial NCT04675463 · UNKNOWN

Trial details

NCT number
NCT04675463
Sponsor
ShiYue Li
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2020-12-30
Primary completion
2023-01-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.